Provided by Tiger Fintech (Singapore) Pte. Ltd.

Xenon Pharmaceuticals

37.84
+0.22000.58%
Post-market: 37.840.00000.00%16:05 EDT
Volume:502.06K
Turnover:18.99M
Market Cap:2.89B
PE:-12.58
High:38.55
Open:37.65
Low:37.45
Close:37.62
Loading ...

Stifel Nicolaus Sticks to Their Buy Rating for Xenon (XENE)

TIPRANKS
·
10 Feb

Wedbush Cuts Price Target on Xenon Pharmaceuticals to $43 From $46, Keeps Outperform Rating

MT Newswires Live
·
23 Jan

Xenon Pharmaceuticals’ CCO Departure and Consultancy Role

TIPRANKS
·
17 Jan

BUZZ-Jefferies raises PT on Xenon Pharmaceuticals

Reuters
·
16 Jan

Xenon Pharmaceuticals Inc : Jefferies Raises Target Price to $65 From $60

THOMSON REUTERS
·
16 Jan

Xenon Pharmaceuticals participates in a conference call with William Blair

TIPRANKS
·
19 Dec 2024

Xenon Pharmaceuticals (XENE) Up 2.4% Since Last Earnings Report: Can It Continue?

Zacks
·
13 Dec 2024

Xenon Pharmaceuticals Price Target Maintained With a $53.00/Share by HC Wainwright & Co.

Dow Jones
·
12 Dec 2024

Promising Efficacy and Tolerability: Douglas Tsao’s Buy Rating on Xenon Pharmaceuticals’ Azetukalner

TIPRANKS
·
12 Dec 2024

Analysts Offer Insights on Healthcare Companies: Xenon (XENE), Legend Biotech (LEGN) and Gilead Sciences (GILD)

TIPRANKS
·
09 Dec 2024

Xenon Pharmaceuticals Reveals Promising Epilepsy Drug Data

TIPRANKS
·
07 Dec 2024

BRIEF-Xenon Showcases New Long-Term Azetukalner Data From X-Tole Ole Study In Fos At Aes 2024

Reuters
·
07 Dec 2024

Xenon Showcases New Long-Term Azetukalner Data From X-Tole Ole Study in Fos at AES 2024

THOMSON REUTERS
·
07 Dec 2024

Xenon Pharmaceuticals Inc - About One in Three Patients on Drug for at Least 36 Months Achieved Seizure Freedom for a Period of One Year or Longer

THOMSON REUTERS
·
07 Dec 2024

Xenon Pharmaceuticals Inc - Ole Data Shows Sustained Monthly Reduction in Seizure Frequency, Consistent Ae Safety Profile

THOMSON REUTERS
·
07 Dec 2024

Xenon Pharmaceuticals named a Best Idea for 2025 at TD Cowen

TIPRANKS
·
05 Dec 2024

Xenon Pharmaceuticals Unveils New Data at AES 2024

TIPRANKS
·
25 Nov 2024

JPMorgan’s ‘Analyst Focus List’ – growth, income, value, short ideas

seekingalpha
·
20 Nov 2024

Promising Prospects and Strategic Advances Drive Buy Rating for Xenon Pharmaceuticals

TIPRANKS
·
14 Nov 2024

Xenon to Present at Upcoming Investor Conferences

GlobeNewswire
·
14 Nov 2024